울산 지역 소아청소년과 및 이비인후과에서의 항염증제 처방 형태 분석
Outpatient Prescription Pattern of Anti-inflammatory Drugs by Pediatricians and ENT Physicians in Ulsan City
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The prescription sheets for outpatients from July 2008 to June 2009 from 7 community pharmacies in Ulsan City were surveyed for the anti-inflammatory drug (AID) prescription pattern. The AID prescription rate of pediatricians and ENT physicians were 30.0% and 34.8%, respectively. The oral steroidal anti-inflammatory drugs (SAIDs) were prescribed as much as 3.9% by pediatricians and 10.3% by ENT physicians. The chiefly prescribed oral SAID was prednisolone in pediatric clinics and methylprednisolone in ENT clinics. Meanwhile the prescription rate of oral non-steroidal antiinflammatory drug (NSAID) was 22.5% by pediatricians and 21.4% in ENT physicians. The most favorable NSAIDs were propionate derivatives in both clinics. In case of externally-applied SAIDs, the prescription rate of pediatricians was 3.6% and that of ENT physicians was 2.8%. Among them, nasal spray, inhalant and gargle formulations for upper respiratory infection (URI) treatment occupied 35.8% of externally-applied SAIDs in pediatric clinics and 59.7% in ENT clinics. Further, it was observed that ENT physicians favored much stronger SAIDs in Group III of ATC classification (75.4% of externally-applied SAIDs) than pediatricians (49.2%). In the survey of AID combination rate, pediatric clinics showed much lower rate (1.4% of total AID prescriptions) than ENT clinics (7.5%). Among them, the combination rate of oral SAID and oral NSAID by ENT physicians (52.2% of total AID combinations) was much higher than pediatricians (36.6%), which might be over-prescription of AID agents. In conclusion, the AID prescription rate as well as AID combination rate, especially in SAID prescriptions, was much higher in ENT than pediatric clinics,which implies the higher confidency on AID drugs of ENT physicians even though the severity of patient's symptom could be considered
Abstract
The prescription sheets for outpatients from July 2008 to June 2009 from 7 community pharmacies in Ulsan City were surveyed for the anti-inflammatory drug (AID) prescription pattern. The AID prescription rate of pediatricians and ENT physicians were 30.0% and 34.8%, respectively. The oral steroidal anti-inflammatory drugs (SAIDs) were prescribed as much as 3.9% by pediatricians and 10.3% by ENT physicians. The chiefly prescribed oral SAID was prednisolone in pediatric clinics and methylprednisolone in ENT clinics. Meanwhile the prescription rate of oral non-steroidal antiinflammatory drug (NSAID) was 22.5% by pediatricians and 21.4% in ENT physicians. The most favorable NSAIDs were propionate derivatives in both clinics. In case of externally-applied SAIDs, the prescription rate of pediatricians was 3.6% and that of ENT physicians was 2.8%. Among them, nasal spray, inhalant and gargle formulations for upper respiratory infection (URI) treatment occupied 35.8% of externally-applied SAIDs in pediatric clinics and 59.7% in ENT clinics. Further, it was observed that ENT physicians favored much stronger SAIDs in Group III of ATC classification (75.4% of externally-applied SAIDs) than pediatricians (49.2%). In the survey of AID combination rate, pediatric clinics showed much lower rate (1.4% of total AID prescriptions) than ENT clinics (7.5%). Among them, the combination rate of oral SAID and oral NSAID by ENT physicians (52.2% of total AID combinations) was much higher than pediatricians (36.6%), which might be over-prescription of AID agents. In conclusion, the AID prescription rate as well as AID combination rate, especially in SAID prescriptions, was much higher in ENT than pediatric clinics,which implies the higher confidency on AID drugs of ENT physicians even though the severity of patient's symptom could be considered
참고문헌 (16)
- Coico R, "Immunology-A Short Course, 6th ed", pp.291~292 (2009), Wiely-Liss
- Barnes PJ, "Anti-inflammatory actions of glucocorticoids: molecular mechanisms", Clin Sci, 94, pp.557~572 (1998)
- Davidson FF, "Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2", Biochem Pharmacol, 38, pp.3645~3651 (1989)
- Marina L, , Mol Cell Biol, 21, pp.771~780 (2001)
- Ben G, "The Endocrine System at a Glance, 2nd ed" (2006), Blackwell Publishing Ltd.
- 김지민, "스테로이드 처방의 허(虛)와 실(實)", 대한내과학회지, 77(3), pp.298~303 (2009), 대한내과학회
- Hilário MO, "Nonsteroidal antiinflammatory drugs: cyclooxygenase 2 inhibitors", J Pediatr (Rio J), 82, pp.S206~S212 (2006)
- Bérard A, "Patterns of drug use in rheumatoid arthritis", J Rheumatol, 27, pp.1648~1655 (2000)
- Price D, "International primary care respiratory group (IPCRG) guidelines: management of allergic rhinitis", Prim Care Respirat J, 15, pp.58~70 (2006)
- "WHO Collaborating Centre for Drug Statistics Methodology", Guideline for ATC classification and DDD assignment 2010, 13th ed, ~ (2009)
- 건강보험공단, "2008년도 건강보험통계연보", 325~ (2009)
- Siklar Z, "An infantile Cushing syndrome due to misuse of topical steroid", Pediatr Dermatol, 21, pp.561~563 (2004)
- Findlay CA, "Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions", BMJ, 317, pp.739~740 (2005)
- Güven A, "Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?", Pediatr Endocrinol Metab, 20, pp.1173~1182 (2007)
- 김성철, "울산 지역 소아청소년과 및 이비인후과에서의 항생제 처방 형태", 한국임상약학회지, 20(2), pp.145~150 (2010), 한국임상약학회